Digestive Diseases

Review Article

Management of Acute Variceal Bleeding

Lata J.a · Hulek P.b · Vanasek T.b

Author affiliations

aDepartment of Internal Medicine and Gastroentrology, Faculty of Medicine, Masaryk University, Brno and bDepartment of Internal Medicine, Faculty of Medicine, Charles University, Hradec Králové, Czech Republic

Keywords: Liver cirrhosisVariceal bleedingTreatmentTransjugular intrahepatic portosystemic shunt

Related Articles for ""
Dig Dis 2003;21:6–15
https://doi.org/10.1159/000071333

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Review Article

Published online: July 03, 2003
Issue release date: 2003

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Abstract

Portal hypertension as a consequence of liver cirrhosis is responsible for its most common complications: ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatic encephalopathy and the most important one – variceal hemorrhage. Variceal bleeding results in considerable morbidity and mortality. This review covers all areas of importance in the therapy of acute variceal hemorrhage – endoscopic and pharmacological treatment, transjugular intrahepatic portosystemic shunt, surgery and balloon tamponade. Indications and limitations of these therapeutic modalities are widely discussed.

© 2003 S. Karger AG, Basel



Related Articles:

References

  1. D’Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A meta-analytic review. Hepatology 1995;22:332–354.
    External Resources
  2. Power W: Contributions to pathology. MD Med Surg J 1940;306–318.
  3. Preble RB: Conclusions based on sixty cases of fatal gastrointestinal hemorrhage due to cirrhosis of the liver. Am J Med Sci 1900;119:263–268.
  4. Terdiman JP: Update on upper gastrointestinal bleeding. Postgrad Med 1998;103:43–64.
  5. Mann NS, Hillis A, Mann SK, Buerk CA, Prasad VM: In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease. Hepatogastroenterology 1999;46:391–394.
    External Resources
  6. Emenike E, Srivastava S, Amoateng-Adjepong Y, Al-Kharrat T, Zarich S, Manthous AC: Myocardial infarction complicating gastrointestinal hemorrhage. Mayo Clin Proc 1999;74:235–241.
    External Resources
  7. De Franchis R (ed): Portal Hypertension. III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford, Blackwell Science, 2001.
  8. De Franchis R (ed): Portal Hypertension. II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford, Blackwell Science, 1996, pp 10–17.
  9. Chalasani N, Patel K, Clark WS, Wilcox CM: The prevalence and significance of leukocytosis in upper gastrointestinal bleeding. Am J Med Sci 1998;315:233–236.
    External Resources
  10. Bernard B, Grange JD, Nyugen Khao E, et al: Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatology 1999;29:1655–1661.
    External Resources
  11. Bhasin DK, Malhi NJS: Variceal bleeding and portal hypertension: Much to learn, much to explore. Endoscopy 2002;43:119–128.
    External Resources
  12. Waring JP, Sanowski RA, Pardy K, et al: Does the addition of methylene blue to the sclerosant improve the accuracy of endoscopic variceal sclerotherapy? Am J Gastroenterol 1990;85:1227.
  13. Burroughs AK, McCormick PA, Hughes MD, et al: Randomized, double-blind placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990;99:1388–1395.
    External Resources
  14. Lo GH, Lai KH, Cheng JS, et al: Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997;25:1101–1104.
    External Resources
  15. Hou MC, Chen WC, Lin HC, et al: A new ‘sandwich’ method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding: A randomized trial. Gastrointest Endosc 2001;53:572–578.
    External Resources
  16. Nakamura S, MItsunaga A, Murata Y, et al: Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: A prospective randomized trial of ligation plus APC vs. ligation alone. Endoscopy 2001;33:210–215.
    External Resources
  17. Bornman P, Terblanche J, Kahn D, et al: Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J 1986;70:34–36.
    External Resources
  18. Sung JY, Yor W, Suen R, et al: Cyanoacrylate vs. sodium tetradecyl sulphate for the injection of bleeding varices in patients with hepatocellular carcinoma: A prospective randomized study. Gastrointest Endosc 1997;45:AB85.
  19. Maluf-Filho F, Sakai P, Ishioka S, et al: Endoscopic sclerosis versus cyanoacrylate endoscopic injection for the first episode of variceal bleeding: A prospective, control and randomized study in Child-Pugh class C patients. Endoscopy 2001;33:421–427.
    External Resources
  20. Lain L, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: A meta-analysis. Ann Intern Med 1995;22:663–665.
  21. Merigan TC, Poltkin GR, Davidson CS: Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. N Engl J Med 1962;266:134–135.
  22. Gimson AES, Westaby D, Hegarty J, et al: A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology 1986;6:410–413.
    External Resources
  23. Jenkins SA, Baxter JN, Corbett WA, et al: A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage. Br Med J 1985;290:275–278.
  24. Cestari R, Graga M, Missale G, et al: Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo-controlled trial. J Hepatol 1990;10:205–210.
    External Resources
  25. Escorsell A, Bandi JC, Moitinho E, et al: Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 1997;26:621–627.
    External Resources
  26. Moreau R, Cailmail S, Valla D, et al: Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats. Aliment Pharmacol Ther 1997;11:993–997.
    External Resources
  27. Huang YT, Lin LC, Chern JW, et al: Portal hypotensive effects of combined terlipressin and DL-028, a synthetic α1-adrenoreceptor antagonist administration on anesthetized portal hypertensive rats. Liver 1999;19:129–134.
    External Resources
  28. Hansen EF, Strandberg C, Hojgaard L, et al: Splanchnic haemodynamic after intravenous terlipressin in anaesthetised healthy pig. J Hepatol 1999;30:503–510.
    External Resources
  29. Soderlund C, Magnusson I, Torngren S, et al: Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990;25:622–630.
    External Resources
  30. Fort E, Sautereau D, Silvain C, et al: A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage. Hepatology 1990;11:678–681.
    External Resources
  31. Walker S, Kreichgauer HP, Bode JC: Terlipressin vs. somatostatin in bleeding esophageal varices: A controlled, double-blind study. Hepatology 1992;15:1023–1030.
    External Resources
  32. Pedretti G: Octreotide vs. terlipressin in acute variceal haemorrhage in liver cirrhosis. Clin Invest 1994;72:653–659.
    External Resources
  33. Escorsell A, Ruiz del Arbol L, Planas R, et al: Multicenter, randomised controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: The TEST Study. Hepatology 2000;32:471–476.
    External Resources
  34. Levacher S, Letoumelin P, Paterson D, et al: Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–868.
    External Resources
  35. Cerini R, Lee SS, Hadengue A, Koshy A, et al: Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension. Gastroenterology 1988;94:703–708.
    External Resources
  36. Hanisch E, Doertenbach J, Usadel KH: Somatostatin in acute bleeding oesophageal varices. Pharmacology and rational for use. Drug 1992;44(suppl):24–35.
  37. Li MK, Sung JJ, Woo KS, et al: Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy: A randomized, double-blind crossover study. Dig Dis Sci 1996;41:2440–2446.
    External Resources
  38. Imperiale T, Teran J, McCullough AJ: A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 1995;109:1289–1294.
    External Resources
  39. Gotzsche P, Gjorup I, Bonnen H, et al: Somatostatin vs. placebo in bleeding esophageal varices – Randomised trial and meta-analysis. BMJ 1995;310:1495–1498.
    External Resources
  40. Shields R, Jenkins SA, Baxter JN, et al: A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 1992;16:128–137.
    External Resources
  41. Burroughs AK, McCormick PA, Hughes MD, et al: Randomized, double-blind placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990;99:1388–1395.
    External Resources
  42. Cales P, Masliah C, Bernad B, et al: Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;344:23–28.
    External Resources
  43. Jenkins SA, Baxter JN, Corbett WA, et al: The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat. Br J Surg 1985;72:864–867.
    External Resources
  44. Moller S, Brinch K, Henriksen JH, et al: Effect of octreotide on systemic, central and splanchnic haemodynamics in cirrhosis. J Hepatol 1997;26:1026–1033.
    External Resources
  45. Escorsell A, Bandi JC, Andreu V, et al: Desensitization to the effect of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 2001;120:161–169.
    External Resources
  46. Avgerinos A, Armonis A, Raptis S: Somatostatin and octreotide in the management of acute variceal hemorrhage. Hepatogastroenterology 1995;42:145–150.
    External Resources
  47. Corley D, Cello J, Adkisson W, et al: Octreotide for acute esophageal variceal bleeding: A meta-analysis. Gastroenterology 2001;120:161–169.
    External Resources
  48. Besson I, Ingrand P, Person B, et al: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;9:555–560.
    External Resources
  49. Jenkins SA, Baxter JN, Critchley M, et al: Randomised trial of octreotide for long-term management of cirrhosis after variceal haemorrhage. BMJ 1997;315:1338–1341.
    External Resources
  50. Stanley AJ, Adrian J, Hayes PC: Portal hypertension and variceal haemorrhage. Lancet 1997;350:1235–1239.
    External Resources
  51. Vlavianos P, Gimson AES, Westaby D, Williams R: Balloon tamponade in variceal bleeding: Use and misuse. BMJ 1989;298:1158–1165.
  52. García-Villareal L, Martínez-Lagares F, Sierra A, et al: Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999;29:27–32.
    External Resources
  53. Richter GM, Palmaz JC, Nöldge G, et al: Der transjugulare intrahepatische portosystemische Stent-Shunt (TIPSS). Radiologie 1989;29:406–411.
  54. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK: ‘Salvage’ transjugular intrahepatic portosystemic shunts: Gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981–987.
    External Resources
  55. Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M: Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: Comparison of emergency and elective interventions. Dig Dis Sci 1998;43:2463–2469.
    External Resources
  56. McCormick PA, Dick R, Panagou EB, Chin JK, Greenslade L, McIntyre N, Burroughs AK: Emergency transjugular intrahepatic portosystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994;81:1324–1327.
    External Resources
  57. Bańares R, Casado M, Rodríguez-Láiz JM, et al: Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998;93:75–79.
    External Resources
  58. Jalan R, John TG, Redhead DN, Garden OJ, Simpson KJ, Finlayson ND, Hayes PC: A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995;90:1932–1937.
    External Resources
  59. Mansilla AV, Putman SG, Cohen GS, et al: Massive hemoptysis secondary to bronchial collaterals: Treatment with use of TIPS and embolization. J Vasc Interv Radiol 1999;10:372–374.
    External Resources
  60. Ryu RK, Nemcek AA, Chrisman HB, et al: Treatment of stomal variceal hemorrhage with TIPS: Case report and review of the literature. Cardiovasc Intervent Radiol 2000;23:301–303.
    External Resources
  61. Haskal ZJ, Scott M, Rubin RA, et al: Intestinal varices: Treatment with the transjugular intrahepatic portosystemic shunt. Radiology 1994;191:183–187.
    External Resources
  62. Ludwig D, Borsa JJ, Maier RV: Transjugular intrahepatic portosystemic shunt for trauma? J Trauma 1999;48:954–956.
    External Resources
  63. Radosevich PM, Ring EJ, LaBerge JM, et al: Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993;186:523–527.
    External Resources
  64. Blum U, Haag K, Rossle M, et al: Noncavernomatous portal vein thrombosis in hepatic cirrhosis: Treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 1995;195:153–157.
    External Resources
  65. Walser EM, McNees SW, DeLa Pena O, et al: Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Interv Radiol 1998;9:119–127.
    External Resources
  66. Bosch J: Transjugular intrahepatic portosystemic shunt (TIPS); in De Franchis R (ed): Portal Hypertension. II. Oxford, Blackwell Science, 1996, pp 127–137.
  67. Chalasani N, Clark WS, Martin LG, et al: Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138–144.
    External Resources
  68. Ochs A, Rössle M, Haag K, et al: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192–1197.
    External Resources
  69. De Franchis R, Primignani M: Why do varices bleed? Gastroenterol Clin North Am 1992;21:85–101.
    External Resources
  70. Cedrona A, Rapaccini GL, Pompili M, et al: Portal vein thrombosis complicating hepatocellular carcinoma: Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver 1996;16:94–98.
    External Resources
  71. Reed MH: TIPS: A liver transplant surgeon’s view. Semin Interv Radiol 1995;12:396–400.
  72. Abouljoud MS, Levy MF, Rees CR, et al: A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transplantation 1995;59:226–229.
    External Resources
  73. Menegaux F, Kneefe EB, Baker E, et al: Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. Ann Surg 1994;129:1018–1024.
  74. Zizka J, Elias P, Krajina A, et al: Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: A 5-year experience in 216 patients. AJR 2000;175:145–148.
  75. Rikkers LF, Sorrell WT, Gongliang J: Which portosystemic shunt is the best? Gastoenterol Clin North Am 1992;21:179–196.
  76. Willson PD, Kunkler R, Blair SD, Reynolds KW: Emergency oesophageal transection for uncontrolled variceal haemorrhage. Br J Surg 1994;81:992–995.
    External Resources
  77. Holt DR, Klein AS: The surgical treatment of portal hypertension: Patient and procedure selection; in Perler B, Becker G (eds): A Clinical Approach to Vascular Intervention. New York, Thieme, 1996, pp 603–608.
  78. Terés J, Baroni R, Bordas JM, Visa J, Pera C, Rodés J: Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding. J Hepatol 1987;4:2, 159–167.
  79. Rosemurgy AS, Bloomston M, Zervos EE, et al: Transjugular intrahepatic portosystemic shunt versus H-graft portacaval shunt in the management of bleeding varices: A cost-benefit analysis. Surgery 1997;122:794–800.
    External Resources
  80. Henderson JM, Nagle A, Curtas S, et al: Surgical shunts and TIPS for variceal decompression in the 1990s. Surgery 2000;128:540–547.
    External Resources
  81. Rössle M: Is there still a need for surgical intervention in portal hypertension? The internist’s point of view; in Krajina A, Hulek P (eds): Current Practice of TIPS, 2001, pp 202–204.
  82. Luca A, D’Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L: TIPS for prevention of recurrent bleeding in patients with cirrhosis: Meta-analysis of randomized trials. Radiology 1999;212:411–421.
    External Resources
  83. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK: Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for the prevention of variceal rebleeding: A meta-analysis. Hepatology 1999;30:612–622.
    External Resources
  84. Millikan WJ Jr, Henderson JM, Galloway JR, Dodson TF, Shires GT 3rd, Stewart M: Surgical rescue for failures of cirrhotic sclerotherapy. Am J Surg 1990;160:117–121.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Review Article

Published online: July 03, 2003
Issue release date: 2003

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2003, Vol.21, No. 1

2003

Article

Recommend This
TOP